Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer (Q46552504)
Jump to navigation
Jump to search
scientific article published on 8 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer |
scientific article published on 8 May 2008 |
Statements
1 reference
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer (English)
1 reference
Hendrik Van Poppel
1 reference
Bertrand Tombal
1 reference
Jean J de la Rosette
1 reference
Bo-Eric Persson
1 reference
Jens-Kristian Jensen
1 reference
Tine Kold Olesen
1 reference
8 May 2008
1 reference
1 reference
54
1 reference
4
1 reference
805-813
1 reference
Identifiers
1 reference
1 reference